Sato Vicki L
- SEC CIK
- 0001197020
In the past year, 9 open-market sale filings worth $1.73M and no purchases.
Current role at each company
- ALLO Allogene Therapeutics, Inc.Directoras of Jun 23, 2026
- VIR Vir Biotechnology, Inc.Directoras of May 4, 2026
- DNLI Denali Therapeutics Inc.Directoras of Jan 3, 2025
- AKUS Akouos, Inc.Directoras of Dec 2, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.73M
- 9 filings
- Net
- −$1.73M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Sato Vicki L as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VIR Vir Biotechnology, Inc.
Director34 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 4, 2026 (view filing) | May 1 | 3 days | Sato Vicki LDirector | SSale | −22.0K | $10.05 | −$221.1K | −2.0%1.08M after | 10b5-1 |
| Apr 2, 2026 (view filing) | Apr 1 | 1 day | Sato Vicki LDirector | SSale | −22.0K | $9.07 | −$199.5K | −2.0%1.10M after | 10b5-1 |
| Mar 3, 2026 (view filing) | Mar 2 | 1 day | Sato Vicki LDirector | SSale | −22.0K | $9.50 | −$209.1K | −1.9%1.12M after | 2 lots10b5-1 |
| Feb 26, 2026 (view filing) | Feb 24 | 2 days | Sato Vicki LDirector | SSale | −42.4K | $9.75 | −$413.3K | −3.6%1.14M after | 2 lots10b5-1 |
| Feb 3, 2026 (view filing) | Feb 2 | 1 day | Sato Vicki LDirector | SSale | −22.0K | $7.71 | −$169.6K | −1.9%1.14M after | 10b5-1 |
| Jan 5, 2026 (view filing) | Jan 2 | 3 days | Sato Vicki LDirector | SSale | −22.0K | $5.93 | −$130.5K | −1.9%1.17M after | 10b5-1 |
| Dec 2, 2025 (view filing) | Dec 1 | 1 day | Sato Vicki LDirector | SSale | −22.0K | $6.00 | −$132.0K | −1.8%1.19M after | 10b5-1 |
| Nov 4, 2025 (view filing) | Nov 3 | 1 day | Sato Vicki LDirector | SSale | −22.0K | $5.64 | −$124.1K | −1.8%1.21M after | 10b5-1 |
| Oct 2, 2025 (view filing) | Oct 1 | 1 day | Sato Vicki LDirector | SSale | −22.0K | $5.84 | −$128.5K | −1.8%1.23M after | 10b5-1 |
| Sep 3, 2025 (view filing) | Sep 2 | 1 day | Sato Vicki LDirector | SSale | −22.0K | $4.99 | −$109.8K | −1.7%1.25M after | 10b5-1 |
DNLI Denali Therapeutics Inc.
Director23 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 3, 2025 (view filing) | Jan 2 | 1 day | Sato Vicki LDirector | SSale | −3.08K | $20.91 | −$64.4K | −2.8%108.0K after | 10b5-1 |
| Nov 12, 2024 (view filing) | Nov 7 | 5 days | Sato Vicki LDirector | SSale | −1.02K | $30.00 | −$30.6K | −0.9%111.1K after | 10b5-1 |
| Nov 5, 2024 (view filing) | Nov 1 | 4 days | Sato Vicki LDirector | SSale | −3.08K | $27.07 | −$83.4K | −2.7%112.1K after | 10b5-1 |
| Sep 16, 2024 (view filing) | Sep 13 | 3 days | Sato Vicki LDirector | SSale | −1.02K | $30.00 | −$30.6K | −0.9%115.2K after | 10b5-1 |
| Sep 4, 2024 (view filing) | Sep 3 | 1 day | Sato Vicki LDirector | SSale | −3.08K | $25.00 | −$77.0K | −2.6%116.2K after | 2 lots10b5-1 |
| Jul 3, 2024 (view filing) | Jul 1 | 2 days | Sato Vicki LDirector | SSale | −3.08K | $22.14 | −$68.2K | −2.5%119.3K after | 2 lots10b5-1 |
| May 17, 2024 (view filing) | May 15 | 2 days | Sato Vicki LDirector | SSale | −1.67K | $20.39 | −$34.1K | −1.4%116.4K after | 10b5-1 |
| Apr 17, 2024 (view filing) | Apr 15 | 2 days | Sato Vicki LDirector | SSale | −1.67K | $18.29 | −$30.5K | −1.4%118.0K after | 10b5-1 |
| Mar 19, 2024 (view filing) | Mar 15 | 4 days | Sato Vicki LDirector | SSale | −1.67K | $20.10 | −$33.5K | −1.4%119.7K after | 10b5-1 |
| Feb 20, 2024 (view filing) | Feb 15 | 5 days | Sato Vicki LDirector | SSale | −1.67K | $18.37 | −$30.6K | −1.4%121.4K after | 10b5-1 |